Cargando…
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
In the field of oncology research, a deeper understanding of tumor biology has shed light on the role of environmental conditions surrounding cancer cells. In this regard, targeting the tumor microenvironment has recently emerged as a new way to access this disease. In this work, a novel extracellul...
Autores principales: | De Vita, Alessandro, Liverani, Chiara, Molinaro, Roberto, Martinez, Jonathan O., Hartman, Kelly A., Spadazzi, Chiara, Miserocchi, Giacomo, Taraballi, Francesca, Evangelopoulos, Michael, Pieri, Federica, Bongiovanni, Alberto, Mercatali, Laura, Tasciotti, Ennio, Ibrahim, Toni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930284/ https://www.ncbi.nlm.nih.gov/pubmed/33658580 http://dx.doi.org/10.1038/s41598-021-84492-3 |
Ejemplares similares
-
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
por: Mercatali, Laura, et al.
Publicado: (2016) -
Management and potentialities of primary cancer cultures in preclinical and translational studies
por: Miserocchi, Giacomo, et al.
Publicado: (2017) -
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
por: De Vita, Alessandro, et al.
Publicado: (2016) -
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
por: Spadazzi, Chiara, et al.
Publicado: (2019) -
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
por: De Vita, Alessandro, et al.
Publicado: (2017)